Innate Pharma SA Current Liabilities
Innate Pharma SA (IPHYF) had Current Liabilities of EUR 36.65 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:CurrentLiabilities · last filed 2026-04-01
- 2025-12-31: Current Liabilities 36.65M EUR.
- 2025-06-30: Current Liabilities 29.43M EUR.
- 2024-12-31: Current Liabilities 32.98M EUR.
- 2024-06-30: Current Liabilities 38.22M EUR.
| Period end | Current Liabilities | Current Liabilities as first filed |
|---|---|---|
| 2025-12-31 | 36.65M EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 29.43M EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | 32.98M EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 38.22M EUR 6-K · filed 2024-09-12 | |
| 2023-12-31 | 39.64M EUR 20-F · filed 2026-04-01 | 39.64M EUR 20-F · filed 2024-04-04 |
| 2023-06-30 | 37.67M EUR 6-K · filed 2023-09-14 | |
| 2022-12-31 | 41.34M EUR 20-F · filed 2025-04-30 | |
| 2022-06-30 | 73.56M EUR 6-K · filed 2022-09-15 | |
| 2021-12-31 | 79.89M EUR 20-F · filed 2024-04-04 | |
| 2021-06-30 | 42.62M EUR 6-K · filed 2021-09-15 | |
| 2020-12-31 | 45.49M EUR 20-F · filed 2023-04-06 | |
| 2019-12-31 | 121.82M EUR 20-F · filed 2022-04-04 | |
| 2018-12-31 | 196.74M EUR 20-F · filed 2021-04-27 | |
| 2017-12-31 | 73.91M EUR 20-F · filed 2020-04-24 |